Fig. 3From: RRx-001, an epigenetic-based radio- and chemosensitizer, has vascular normalizing effects on SCCVII and U87 tumors a Effect of RRx-001 (ABDNAZ) treatment on blood flow and tissue hypoxia in SCCVII tumors. b Comparison of RRx-001 (ABDNAZ) effect on tumor architecture, blood flow, hypoxia, and HIF1-α status in SCCVII tumorsBack to article page